HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S O Kim Selected Research

N''- cyano- N- (6- amino- 3,4- dihydro- 3- hydroxy- 2- methyl- 2- dimethoxymethyl- 2H- benzopyran- 4- yl)- N'- benzylguanidine

3/2001High-performance liquid chromatographic analysis of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378.
1/2001Blood partition and protein binding of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378.
10/2000Dose-dependent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378, in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S O Kim Research Topics

Disease

6Ischemia
01/2010 - 02/2000
3Reperfusion Injury
03/2001 - 10/2000
2Infarction (Infarctions)
01/2010 - 02/2000
1Chronic Obstructive Pulmonary Disease (COPD)
01/2020
1Basal Cell Carcinoma (Rodent Ulcer)
10/2015
1Myocardial Infarction
01/2010
1Chronic Pain
05/2009
1Hyperalgesia
05/2009
1Reflex Sympathetic Dystrophy (Reflex Sympathetic Dystrophy Syndrome)
05/2009
1Pain (Aches)
05/2009
1Hepatocellular Carcinoma (Hepatoma)
10/2008
1Encephalitis (Encephalitis, Rasmussen)
08/2001
1Japanese Encephalitis
08/2001
1Ovarian Neoplasms (Ovarian Cancer)
08/2001
1Carcinogenesis
08/2001
1Necrosis
01/2001
1Wounds and Injuries (Trauma)
09/2000
1Carcinoma (Carcinomatosis)
06/2000

Drug/Important Bio-Agent (IBA)

3Neuroprotective AgentsIBA
03/2001 - 10/2000
3N''- cyano- N- (6- amino- 3,4- dihydro- 3- hydroxy- 2- methyl- 2- dimethoxymethyl- 2H- benzopyran- 4- yl)- N'- benzylguanidineIBA
03/2001 - 10/2000
2Proteins (Proteins, Gene)FDA Link
01/2010 - 08/2001
2AnisomycinIBA
06/2000 - 02/2000
2p38 Mitogen-Activated Protein KinasesIBA
06/2000 - 02/2000
1Carbon MonoxideIBA
01/2020
1Opioid Analgesics (Opioids)IBA
01/2010
1Cytochromes c (Cytochrome c)IBA
01/2010
1Remifentanil (Ultiva)FDA Link
01/2010
1Allopurinol (Remid)FDA LinkGeneric
05/2009
1Superoxides (Superoxide)IBA
05/2009
1AntioxidantsIBA
05/2009
1prostaglandin-inositol cyclic phosphateIBA
05/2009
1Analgesics (Analgesic Drugs)IBA
05/2009
1Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2009
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2009
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
05/2009
1Caspase 3 (Caspase-3)IBA
10/2008
1VaccinesIBA
08/2001
1Inactivated VaccinesIBA
08/2001
1Protein Kinases (Protein Kinase)IBA
08/2001
1ChromatinIBA
01/2001
1oxidized low density lipoproteinIBA
09/2000
1ThymidineIBA
09/2000
1EnzymesIBA
06/2000
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2000
1arseniteIBA
06/2000
1SB 203580IBA
06/2000
1MAP-kinase-activated kinase 2IBA
02/2000
1GenisteinIBA
02/2000

Therapy/Procedure

1Minor Surgical Procedures (Minor Surgery)
10/2015
1Anesthesia
01/2010
1Therapeutics
10/2008
1Oral Administration
10/2000